Glucotrack, Inc. — Form 8-K
Filed July 27, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 78/100
What the filing says
On July 22, 2026, Glucotrack agreed to partition $900,000 from a $3.6M promissory note (issued Sept 12, 2025; previously reduced by $1.588M via two prior exchanges in April 2026) and convert the partitioned amount into common shares at the lower of the prior day's closing price or 5-day average, with a 9.99% beneficial ownership cap. Shares are free-trading, issued in tranches on lender request, with holding period tacking to the original September 2025 note date.
Why this rating
Debt-to-equity conversion of ~$900K (17% of $5.4M market cap) is material in scale. No cash outlay required, but significant dilution ahead and continued obligation on remaining ~$1.012M note balance. Lender identity withheld; terms are typical convertible mechanics, not transformational.
See more from July 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.